XML 28 R6.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Notes Receivables from Stockholders
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Gain/(Loss)
Beginning balance (in shares) at Dec. 31, 2023 [1]   15,035,467        
Beginning balance at Dec. 31, 2023 $ 122,600 $ 2 [1] $ (10,111) $ 1,838,499 [1] $ (1,704,076) $ (1,714)
Increase (Decrease) in Stockholders' Equity            
Adjustment of transaction costs related to Business Combination (2,372)     (2,372) [1]    
Issuance of common stock for options exercised (in shares) [1]   6,814        
Issuance of common stock for options exercised 1,560     1,560 [1]    
Cancellation of common stock (in shares) [1]   (30,673)        
Stock-based compensation 28,534     28,534 [1]    
Tax withholding upon vesting of restricted stock units (in shares) [1]   (67,235)        
Tax withholding upon vesting of restricted stock units (1,972)     (1,972) [1]    
Shares issued for vested restricted stock units (in shares) [1]   224,422        
Vesting of common stock issued via notes receivable from stockholders (8)   (893) 885 [1]    
Settlement of notes receivable from stockholders     1,846 (1,846) [1]    
Net loss (206,290)       (206,290)  
Other comprehensive gain (loss)— foreign currency translation adjustment, net of tax $ (222)         (222)
Ending balance (in shares) at Dec. 31, 2024 15,168,795 15,168,795 [1]        
Ending balance at Dec. 31, 2024 $ (58,170) $ 2 [1] (9,158) 1,863,288 [1] (1,910,366) (1,936)
Increase (Decrease) in Stockholders' Equity            
Gain on troubled debt restructuring 210,044     210,044    
Tax effect on gain on troubled debt restructuring $ (741)     (741)    
Issuance of common stock for options exercised (in shares) 1,515 1,516        
Issuance of common stock for options exercised $ 19     19    
Issuance of common stock under ATM program (in shares)   547,260        
Issuance of common stock under ATM program 29,221     29,221    
Termination of notes receivable from stockholders (in shares)   (20,855)        
Termination of notes receivable from stockholders 0   9,158 (9,158)    
Stock-based compensation 21,851     21,851    
Tax withholding upon vesting of restricted stock units (in shares)   (161,422)        
Tax withholding upon vesting of restricted stock units (4,818)     (4,818)    
Shares issued for vested restricted stock units (in shares)   456,417        
Issuance of common stock – other (in shares)   5,196        
Issuance of common stock – other 56     56    
Net loss (165,872)       (165,872)  
Other comprehensive gain (loss)— foreign currency translation adjustment, net of tax $ 5,593         5,593
Ending balance (in shares) at Dec. 31, 2025 15,996,907 15,996,907        
Ending balance at Dec. 31, 2025 $ 37,183 $ 2 $ 0 $ 2,109,762 $ (2,076,238) $ 3,657
[1] Periods have been adjusted to reflect the 1-for-50 reverse stock split on August 16, 2024. See Note 1 Organization and Nature of the Business - Reverse Stock Split, for additional information.